Posaconazole and Hepatitis cholestatic - a phase IV clinical study of FDA data

Summary:

Hepatitis cholestatic is reported as a side effect among people who take Posaconazole (posaconazole), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Azacitidine, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Hepatitis cholestatic when taking Posaconazole. It is created by eHealthMe based on reports of 9,473 people who have side effects when taking Posaconazole from the FDA, and is updated regularly.

What is Posaconazole?

Posaconazole has active ingredients of posaconazole. eHealthMe is studying from 9,475 Posaconazole users. Check the latest studies of Posaconazole.

What is Hepatitis cholestatic?

Hepatitis cholestatic (flow of bile from the liver is slowed or blocked) is found to be associated with 546 drugs and 824 conditions by eHealthMe. Check the latest studies of Hepatitis cholestatic.

On Jul, 19, 2026

9,473 people reported to have side effects when taking Posaconazole.
Among them, 19 people (0.2%) have Hepatitis cholestatic.

Could Posaconazole cause Hepatitis cholestatic?

Among these 19 people:

How long have people been on Posaconazole when they have Hepatitis cholestatic? *

What is the gender of people who have Hepatitis cholestatic when taking Posaconazole? *

female: 72.22 %
male: 27.78 %

What is the age of people who have Hepatitis cholestatic when taking Posaconazole? *

What are other drugs people take besides Posaconazole? *

Azacitidine: 6 people, 31.58%
Neupogen: 5 people, 26.32%
Neoral: 5 people, 26.32%
Acyclovir: 5 people, 26.32%
Imipenem And Cilastatin: 4 people, 21.05%
Nexium: 4 people, 21.05%
Levofloxacin: 2 people, 10.53%
Azithromycin: 1 person, 5.26%
Compazine: 1 person, 5.26%
Mycophenolate Mofetil: 1 person, 5.26%

What are other side effects people have besides Hepatitis cholestatic? *

Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 5 people, 26.32%
Diarrhea: 5 people, 26.32%
Adenovirus Infection: 4 people, 21.05%
Fever: 4 people, 21.05%
Thrombocytopenia (decrease of platelets in blood): 4 people, 21.05%
Hypertriglyceridaemia (excess of triglycerides in the blood): 4 people, 21.05%
Hair Color Changes: 3 people, 15.79%
Neuropathy Peripheral (surface nerve damage): 3 people, 15.79%
Pancreatic Disorder: 3 people, 15.79%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 15.79%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 42.11%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 26.32%
Mycobacterial Infection: 4 people, 21.05%
Mycobacterium Abscessus Infection (rapid growing bacterial infection): 3 people, 15.79%
Hypertriglyceridaemia (excess of triglycerides in the blood): 3 people, 15.79%
Lung Disorder (lung disease): 2 people, 10.53%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 10.53%
Immunodeficiency Disorders: 1 person, 5.26%
Headache (pain in head): 1 person, 5.26%
Bone Marrow Failure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Posaconazole and have Hepatitis cholestatic?

- Check whether Hepatitis cholestatic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Posaconazole:

Posaconazole (9,475 reports)

Browse all side effects of Posaconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis cholestatic:

Hepatitis cholestatic (547 drugs)

Browse all the conditions that are associated with Hepatitis cholestatic:

Hepatitis cholestatic (824 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole (the active ingredients of Posaconazole) and Posaconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.